In this setting mice injected with LNCaP cells expressing ADAMTS-15 showed no survival advantage when compared to those injected with cells expressing ADAMTS-15EA or pcDNA3.1 controls, with tumor growth rates no longer significantly different. This evidence concerns the gene ADAMTS15 and neoplasm.